Rheumatoid arthritis and Nail abnormalities
Summary:
Nail abnormalities is found among people with Rheumatoid arthritis, especially for people who are female, 60+ old.
The study analyzes which people have Nail abnormalities with Rheumatoid arthritis. It is created by eHealthMe based on reports of 51 people who have Rheumatoid arthritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Rheumatoid arthritis?
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 1,671 drugs and 2,130 conditions by eHealthMe. Check the latest studies of Rheumatoid arthritis.
What is Nail abnormalities?
Nail abnormalities (abnormal nail) is found to be associated with 210 drugs and 652 conditions by eHealthMe. Check the latest studies of Nail abnormalities.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
51 people who have Rheumatoid Arthritis and Nail Abnormalities are studied.

Gender of people who have Rheumatoid Arthritis and experienced Nail Abnormalities *:
- female: 79.17 %
- male: 20.83 %
Age of people who have Rheumatoid Arthritis and experienced Nail Abnormalities *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 2.27 %
- 30-39: 0.0 %
- 40-49: 9.09 %
- 50-59: 27.27 %
- 60+: 61.36 %
Common co-existing conditions for these people *:
- High Blood Pressure: 6 people, 11.76%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 11.76%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 7.84%
- High Blood Cholesterol: 4 people, 7.84%
- Anaemia (lack of blood): 4 people, 7.84%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.88%
- Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.88%
- Osteoporosis (bones weak and more likely to break): 3 people, 5.88%
- Thyroid Diseases: 2 people, 3.92%
- Diabetes: 1 person, 1.96%
Common drugs taken by these people *:
- Xeljanz Xr: 13 people, 25.49%
- Arava: 13 people, 25.49%
- Enbrel: 12 people, 23.53%
- Humira: 11 people, 21.57%
- Vitamin D: 7 people, 13.73%
- Robaxin: 7 people, 13.73%
- Xeljanz: 7 people, 13.73%
- Lotrel: 6 people, 11.76%
- Singulair: 6 people, 11.76%
- Neurontin: 6 people, 11.76%
Common symptoms for these people *:
- Pain In Extremity: 12 people, 23.53%
- Rashes (redness): 11 people, 21.57%
- Gait Disturbance: 11 people, 21.57%
- Back Pain: 10 people, 19.61%
- Hypoaesthesia (reduced sense of touch or sensation): 10 people, 19.61%
- Drug Ineffective: 10 people, 19.61%
- Depression: 10 people, 19.61%
- Impaired Healing: 9 people, 17.65%
- Weakness: 9 people, 17.65%
- Swelling: 8 people, 15.69%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Nail abnormalities?
- Check whether Nail abnormalities is associated with a drug or a conditionRelated publications that referenced our studies
- Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
- Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Rheumatoid arthritis (1,091,836 reports)
- Nail abnormalities (2,346 reports)
All the drugs that are associated with Nail abnormalities:
- Nail abnormalities (210 drugs)
All the conditions that are associated with Nail abnormalities:
- Nail abnormalities (652 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Nail abnormalities and Rheumatoid arthritis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aloxi cause Paronychia? - 3 seconds ago
- Could Onpattro cause Memory Loss? - 9 seconds ago
- Could Remodulin cause Gingival Bleeding? - 17 seconds ago
- Could Ranitidine Hydrochloride cause Allergy To Chemicals? - 19 seconds ago
- Could Albuterol cause Nipple Pain? - 31 seconds ago
- Could Rabeprazole cause Bundle Branch Block Right? - 40 seconds ago
- Could Norvir cause Hospitalisation? - 41 seconds ago
- Could Rabeprazole Sodium cause Asthma? - 42 seconds ago
- Could Yervoy cause Weight Loss? - 43 seconds ago
- Could Rabeprazole cause Joint Destruction? - 44 seconds ago